Efficacy and safety of long-term use of low molecular weight heparins in patients with systemic lupus erythematosus and antiphospholipid syndrome
To date, the management of patients with antiphospholipid syndrome (APS) with ineffectiveness and/or intolerance to vitamin K antagonists and direct oral anticoagulants remains controversial. One of the treatment strategies is the administration of low molecular weight heparins (LMWH) over a long pe...
Saved in:
Main Authors: | N. V. Seredavkina, F. A. Cheldieva, A. A. Shumilova, T. M. Reshetnyak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2023-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1471 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01) -
The methods of assessment of quality and safety of medicaments on the basis of low molecular weight heparins
by: E. A. Arianova, et al.
Published: (2011-09-01) -
Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01) -
Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01) -
Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review
by: Huixin Zhao, et al.
Published: (2025-07-01)